Deciphering the molecular heterogeneity of intermediate- and (very-)high-risk non–muscle-invasive bladder cancer using multi-layered –omics studies

Bladder cancer (BC) is the most common malignancy of the urinary tract. About 75% of all BC patients present with non-muscle-invasive BC (NMIBC), of which up to 70% will recur, and 15% will progress in stage and grade. As the recurrence and progression rates of NMIBC are strongly associated with som...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Murat Akand, Tatjana Jatsenko, Tim Muilwijk, Thomas Gevaert, Steven Joniau, Frank Van der Aa
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2024-10-01
Reeks:	Frontiers in Oncology
Onderwerpen:	bladder cancer recurrence progression non-muscle-invasive -omics genomics
Online toegang:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1424293/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!